Factores asociados a shock vasopléjico en el postoperatorio de cirugía cardiaca e influencia en la morbimortalidad del uso de arginina vasopresina como terapia de rescate
María Barrera Sánchez, Cristina Royo Villa, Pablo Ruiz de Gopegui Miguelena, Pablo Gutiérrez Ibañes, Andrés Carrillo López
{"title":"Factores asociados a shock vasopléjico en el postoperatorio de cirugía cardiaca e influencia en la morbimortalidad del uso de arginina vasopresina como terapia de rescate","authors":"María Barrera Sánchez, Cristina Royo Villa, Pablo Ruiz de Gopegui Miguelena, Pablo Gutiérrez Ibañes, Andrés Carrillo López","doi":"10.1016/j.medin.2024.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Analizing associated factors with vasoplegic shock in the postoperative period of cardiac surgery. Analizing the influence of vasopressin as rescue therapy to first-line treatment with norepinephrine.</p></div><div><h3>Design</h3><p>Cohort, prospective and observational study.</p></div><div><h3>Setting</h3><p>Main hospital postoperative cardiac ICU.</p></div><div><h3>Patients</h3><p>Patients undergoing cardiac surgery with subsequent ICU admission from January 2021 to December 2022.</p></div><div><h3>Interventions</h3><p>Record of presurgical, perioperative and ICU discharge clinical variables.</p></div><div><h3>Main variables of interest</h3><p>Chronic treatment, presence of vasoplegic shock, need for vasopressin, cardiopulmonary bypass time, mortality.</p></div><div><h3>Results</h3><p>773 patients met the inclusion criteria. The average age was 67.3, with predominance of males (65.7%). Post-CPB vasoplegia was documented in 94 patients (12.2%). In multivariate analysis, vasoplegia was associated with age, female sex, presurgical creatinine levels, cardiopulmonary bypass time, lactate level upon admission to the ICU, and need for prothrombin complex transfusion. Of the patients who developed vasoplegia, 18 (19%) required rescue vasopressin, associated with pre-surgical intake of ACEIs/ARBs, worse EuroScore score and longer cardiopulmonary bypass time. Refractory vasoplegia with vasopressin requirement was associated with increased morbidity and mortality.</p></div><div><h3>Conclusions</h3><p>Postcardiopulmonary bypass vasoplegia is associated with increased mortality and morbidity. Shortening cardiopulmonary bypass times and minimizing products blood transfusion could reduce its development. Removing ACEIs and ARBs prior to surgery could reduce the incidence of refractory vasoplegia requiring rescue with vasopressin. The first-line treatment is norepinephrine and rescue treatment with vasopressin is a good choice in refractory situations. The first-line treatment of this syndrome is norepinephrine, although rescue with vasopressin is a good complement in refractory situations.</p></div>","PeriodicalId":49268,"journal":{"name":"Medicina Intensiva","volume":"48 7","pages":"Pages 392-402"},"PeriodicalIF":2.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Intensiva","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210569124000822","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Analizing associated factors with vasoplegic shock in the postoperative period of cardiac surgery. Analizing the influence of vasopressin as rescue therapy to first-line treatment with norepinephrine.
Design
Cohort, prospective and observational study.
Setting
Main hospital postoperative cardiac ICU.
Patients
Patients undergoing cardiac surgery with subsequent ICU admission from January 2021 to December 2022.
Interventions
Record of presurgical, perioperative and ICU discharge clinical variables.
Main variables of interest
Chronic treatment, presence of vasoplegic shock, need for vasopressin, cardiopulmonary bypass time, mortality.
Results
773 patients met the inclusion criteria. The average age was 67.3, with predominance of males (65.7%). Post-CPB vasoplegia was documented in 94 patients (12.2%). In multivariate analysis, vasoplegia was associated with age, female sex, presurgical creatinine levels, cardiopulmonary bypass time, lactate level upon admission to the ICU, and need for prothrombin complex transfusion. Of the patients who developed vasoplegia, 18 (19%) required rescue vasopressin, associated with pre-surgical intake of ACEIs/ARBs, worse EuroScore score and longer cardiopulmonary bypass time. Refractory vasoplegia with vasopressin requirement was associated with increased morbidity and mortality.
Conclusions
Postcardiopulmonary bypass vasoplegia is associated with increased mortality and morbidity. Shortening cardiopulmonary bypass times and minimizing products blood transfusion could reduce its development. Removing ACEIs and ARBs prior to surgery could reduce the incidence of refractory vasoplegia requiring rescue with vasopressin. The first-line treatment is norepinephrine and rescue treatment with vasopressin is a good choice in refractory situations. The first-line treatment of this syndrome is norepinephrine, although rescue with vasopressin is a good complement in refractory situations.
期刊介绍:
Medicina Intensiva is the journal of the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC) and of Pan American and Iberian Federation of Societies of Intensive and Critical Care Medicine. Medicina Intensiva has become the reference publication in Spanish in its field. The journal mainly publishes Original Articles, Reviews, Clinical Notes, Consensus Documents, Images, and other information relevant to the specialty. All works go through a rigorous selection process. The journal accepts submissions of articles in English and in Spanish languages. The journal follows the publication requirements of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).